Observational studyFrontiers in immunology2026

Ravulizumab in neuromyelitis optica spectrum disorder: first clinical experience in Chile.

Tamara Santibáñez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.